Antibiotic prescriptions among dentists across Norway and the impact of COVID-19 pandemic.

Tousi, Farnoush; Al Haroni, Mohammed; Lie, Stein Atle; Lund, Bodil

Tousi, Farnoush; Al Haroni, Mohammed; Lie, Stein Atle; Lund, Bodil.

Afiliación

Tousi F; Department of Clinical Dentistry, University of Bergen, Bergen, Norway.
Al Haroni M; Department of Maxillofacial Surgery, Haukeland University Hospital, Bergen, Norway.
Lie SA; Department of Clinical Dentistry, Faculty of Health Sciences, UiT the Arctic University of Norway, Tromsø, Norway. mohammed.al-haroni@uit.no.
Lund B; Centre for New Antimicrobial Strategies, UiT the Arctic University of Norway, Tromsø, Norway. mohammed.al-haroni@uit.no.

BMC Oral Health ; 23(1): 649, 2023 09 08.

Article en En | MEDLINE | ID: mdl-37684614

Asunto(s)

Antibacterianos; COVID-19; Humanos; Antibacterianos/uso terapéutico; Pandemias; Amoxicilina; Noruega/epidemiología; Prescripciones; Odontólogos

Palabras clave

Amoxicillin; Antibiotic prescription; COVID-19; Clavulanic acid; Clindamycin; Co-amoxiclav; Consumption; Defined daily doses (DDD); Dentist; Dentistry; Metronidazole; Phenoxymethyl penicillin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Antibacterianos Tipo de estudio: Guideline Límite: Humans País/Región como asunto: Europa Idioma: En Revista: BMC Oral Health Asunto de la revista: ODONTOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google